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 Breast cancer is the most common cancer among the women and makes up one- third of cancers. Telomerase enzyme is a 
ribonucleoprotein with reverse transcriptase activity that adds TTAGGG repeated sequences to the ends of the chromosomes. The 
expression of the catalytic subunit of the enzyme (hTERT) in cancer cell lines and different human tumors is shown. So, in this study, the 
proliferation of copies of the hTERT gene in primary breast cancer was studied. Materials and Methods : Forty five Paraffin tissue samples 
from breast cancer patients and forty five Paraffin tissue samples from  breast non-neoplastic patients  was provided from Ardabil Imam 
Khomeini Hospital’s Pathology section and Plasma Laboratory.DNA samples were extracted with phenol-chloroform manually, then Real 
Time PCR was done with hTERT Forward, and Reverse primers and GAPDH Forward, and Reverse. The tumor sample was compared 
with the non- tumor one to investigate proliferation of copies of the hTERT gene as a prognostic indicator in patients with primary breast 
cancer. Results: Real time PCR curve analysis for hTERT and GAPDH genes in tumor samples compared with non-tumor samples showed 
that, there is no statistical deference’s between them (p=0.322). For data analysis Spss statistical software was used. Discussion: Our 
current studies on results of amplification hTERT gene, in comprising tumors samples with non-tumors is indication of early prognosis in 
primary breast cancer patients. While amplification of hTERT gene  in breast cancer patients compared to the control group indicates that 
there is no statistical deference’s between them and it  couldn’t be considered as prognosis factor for the primary breast cancer patients. 
 





 Breast cancer is the most common malignant 
disease in women all over the world and constitutes 
one-third of cancers and after lung cancer is 
considered the second leading cause of cancer 
mortality in women [1,2]. 
 This disease is increased in Iran and since 1999 
has the first country rank among recorded cancers 
[3,4]. Due to lack of organized screening and training 
programs for initial and early detection of breast 
cancer in Iran, about 70 % of Iranian women are 
diagnosed in dangerous stages of the disease [5]. 
According to the cancer registration, breast cancer in 
Ardabil is the most common one, following 
esophagus and stomach cancers [6].  
 Telomerase enzyme is a ribonucleoprotein 
complex of telomere-specific reverse transcriptase 
activity that uses an RNA template for adding 
TTAGGG repeated sequences to the ends of the 
chromosomes, and compensates for the loss of the 
telomere length. So telomeres are replicated  by the 
telomerase enzyme [7,8,9,10,11,12,13].  
 Human telomerase enzyme activity is composed 
of the human telomerase reverse transcriptase 
(hTERT), human telomerase RNA (hTR) and 
Dyskryn [14]. 
 Telomerase enzyme activity does not exist in 
normal somatic cells, but It  is  seen  in 85 % - 90 % 
of human cancers, including more than 95 %  of 
breast cancers, which is essential for continued 
proliferation [15]. A limited number of cancers 
(15%) preserve telomeres through recombination 
mechanism with an alternative of telomere length 
(ALT) [16]. 
 hTERT is expressed only in the telomerase cells 
and is not expressed in differentiated cells [17,18]. 
hTERT gene will amplify abundantly in human 
tumors and tumor cell lines. This result implies that 
an increase in copy numbers of hTERT gene, can be 
involved in the regulation of telomerase expression 
in the immortalized cells [19,20]. It is also shown 
that hTERT is a decisive factor for controlling 
telomerase activity [18,21,22,23]. 
 Reproduction of the catalytic subunit of the 
enzyme (hTERT) in cancer cell lines and different 
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human tumors is shown. So, in this study, the 
proliferation of copies of the hTERT gene in primary 
breast cancer was studied.  
 
Materials and Method 
 
 Forty five breast cancer formalin fixed paraffin 
embedded (FFPE) specimens obtained from the 
Department of surgery, Imam Hospital, Ardabil, Iran. 
All patients signed detailed consent forms before the 
study was conducted. The experimental samples 
were pre-made on standard slides with 5 micron 
thick FFPE tissues using the standard method by the 
Department of Pathology, Imam Hospital. 
  3-5 slices of 5 micron from selected samples 
placed in the 1.5 ml micro- tube and DNA samples 
were extracted with phenol-chloroform manually 
with using  xylol, ethanol, Layzyz buffer, proteinase 
K, phenol saturated, chloroform - isoamyl alcohol, 
sodium acetate, isopropanol and the finally  50 
micro- liter of distilled water added. 
 Then the sample for hTERT gene put through  
PCR, .For each process, 120 μl of buffer10 X, 36 μl 
of Mgcl2, 24 μl of dNTPs, 1 μl of primers Forward 
(F) and Reverse (R), 0.1 μl of the enzyme Taq DNA 
polymerase and 2 μl of DNA was used.  
 Sequences of primers used for F = 
5΄AGTGGAGACAGGCGCAT3΄and R =5΄ 
ATGGTGAGTGCTACATGGTGA3΄.   
 Samples that were put through PCR processed in 
the beginning at 95˚C for 30 min, then 35 cycles of 
95˚C for  30 sec, 35 cycles of 56˚ C for 30 sec, 35 
cycles of 72˚C for 30 sec, and finally at 72˚C for 7 
min. PCR products were electrophoresed at 0.01 
agarose gel. 
 Then all of the samples in addition to hTERT 
gene for GAPDH gene with  primer sequences  F = 
5΄CTCTCTGCTCCTCCTGTTCGAC 3΄ and R 
=5΄TGAGCGATGTGGCTCGGCT 3΄ were gone 
through Real Time PCR process. Forty five tumor 
samples and forty five non-tumor samples were 
compared to increased amplification of hTERT gene 
are reviewed as a prognostic marker for the Primary 
breast cancer patients. 
 Samples were put through  Real Time PCR in 
the beginning at 50˚C for 2 min , then at 95˚C for 10 
min, 60 cycles of 95˚C for 15 sec and finally 60 
cycles of 60˚C 1 min. 
 
Results: 
 In this experiment, Forty five paraffin-embedded 
tumor samples from breast cancer patients and 45 
paraffin tissue samples from control group was 
provided and investigations were carried out on 
them, the results are as follows. 
 After the DNA tumor and non- tumor samples 
was extracted, PCR was performed to ensure the 
absence of primer dimmer. Then the PCR products 
were analyzed by gel electrophoresis. 
 To check the purity of the DNA extracted from 
nano- drop device was used. Absorbance reading 
DNA, extracted DNA quality can be achieved. 
Relative absorbance (Optical Density: OD) DNA at 
wavelengths 260 to 280 nm was measured. Higher 
OD at wavelengths 280/260 of 1.8 is an indicator of 
DNA purity. Different concentrations of DNA 
samples, using the formula C1.V1 = C2.V2 
Nanodrop apparatus were identical and were given 
20 ng micro liter [5]. 
 Quantification increased amplification of hTERT 
and GAPDH gene in breast cancer patients compared 
with those without tumor was performed. Real time 
PCR curves amplification of hTERT gene in tumor 




Fig. 1: The curve increased amplification of hTERT gene in samples from patients and control group in the 
experimental Real time PCR. The amount of fluorescence emitted increased during the cycle of the of 
increased PCR products amounts. 
 
 The average numbers of hTERT on group of 
Cancer Patient are 19 ± 4.8 and in control group 
these numbers were 18.6 ± 4 which show that, there 
is no visible deference in computed average numbers 
between control group with] group of cancer patients 
(Figure 2). In cancer patients and control groups the 
OR=1.4 and the confidence interval (CT) is equal 
with 0.9 – 2.2 which shows no noticeable deference 
between two groups. 
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Fig. 2: Amplification of  hTERT gene in breast cancer patients compared to the Control group indicates that, 
there is no statistical association existed between them. 
 
 Descriptive data of all samples of the Cancer 
Patients, at stage one, 2 cases (% 4.4), at stage two, 
25 cases (% 55.6) at stage three, 18 cases (% 40) are 
shown (Table1). 
  
Table 1: The condition of the stages. 
 Frequency Percent 
Valid 1 2 4.4 
2 25 55.6 
3 18 40.0 
Total 45 100.0 
 
 Interpretation of results was done using the 
comparative CT method for quantitation according to 
this arithmetic formulas: 
 
    ∆CT= CT target  - CT refrence 
hTERT adjusted = 2 
- ∆ ct
   
 The mean  total in Cancer Groups 20273 ± 
135993   and in control group it is 91 ± 601 which 




 Breast cancer is the most common cancer in 
women the world [24]. Telomerase is a 
ribonucleoprotein enzyme consisting of two parts. 
The first part, subunit active catalytic protein, hTERT 
reverse transcriptase activity that adds telomere 
repeated sequences to the ends of the chromosomes 
and that is essential to the continued growth of tumor 
cells. hTERT gene is increasingly amplified in human 
tumors and tumor cell lines. 
 The secondary part of the template RNA in 
humans is called hTR and used as a template for 
telomere synthesis. Telomerase is an therapy target 
for ideal anticancer because of its activities in more 
than 90 % of human cancers, there are including 
more than 95 % breast cancer, whereas most somatic 
cells are indistinguishable [25]. 
 Thomas and his colleagues, have also concluded 
the amplification of hTERT gene in Lanfobelastic 
acute leukemia (ALL) and non Lanfobelastic 
leukemia (ANLL). Quantitative analysis showed that 
leukemia cells have many numbers of the copies of 
hTERT, hTERC are normal PBL. The results indicate 
that telomerase activity in leukemia cells is 
associated with amplification of hTERT gene, hTERC 
[26]. 
 Richard and his colleagues   in 2005  to increase 
the hTERT gene  copy number in samples from 64 
colorectal carcinomas  were reviewed and increased 
copy number (>= 3  hTERT gene copies/ nucleus)  
were observed in 31(48%) cases. No correlation was 
found between hTERT gene  copy number and 
hTERT RNA expression or telomerase activity. Data 
show increase in copy number of the hTERT gene in 
colorectal carcinoma was the result of unstable 
telomerase activity levels was not associated [27]. 
 Ying and colleagues studies, amplification of 
hTERT gene was observed in cell lines tumors and 
various human cancers, as well as a mechanism of 
telomerase activation is introduced. It is remarkable 
that telomerase activity increases in both of the 
primary cells and cancer [28]. 
 In 2008, based on studies in Russia, the hTERT 
DNA copy number of the 33 studied tumors 
compared to normal tissues was unchanged. Similar 
results was achieved with squamous cell cervical 
carcinomas (SCC) cell lines in human papillom 
virus(HPV)genomes.However, the activation of 
hTERT expression was discovered in 80% of cases 
(37/46, p<0.001). There was no relationship between 
the  degree of mRNA increase and the tumor size 
and/or prevalence metastases. No hTERT gene 
expression was  shown  in 20% of cases(9/46), while 
the control GAPDH expression has remained 
unchanged.   The conclusion was that, the frequent 
activation of  hTERT expression in SCC is not  
linked with gene amplification [29]. 
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 Zhang and colleagues Saretzki have been 
reported a link between two TERT genes and 
telomerase activity in multiple cell line and primary 
tumors, the study Palmqvist primary tumors of 
samples and other studies of the stability of human 
breast epithelial cells and human foreskin fibroblasts  
no correlation were not observed between the copies 
number of hTERT genes and telomerase activity. No 
relationship could be observed a complex the 
telomerase enzyme, consisting of components and 
multiple evidence, telomerase activity is limited to 
the level two components (hTERT and hTR) [30]. 
 
Top of Form: 
 In a variety of tumors, increasing the copy 
number of the TERT has clinical relevance and 
prognosis For example, Zhu and his colleagues have 
shown that Lung Cancer Patients with increased 
amplification of hTERT with reoccurs will not last 
long. In melanoma, copies of increased amplification 
of hTERT correlated to subunits of melanoma and era 
of metastasis. Also the research shows that, 
Amplefication of hTRET in different cell line 
normally is independent of telomerase activities [31]. 
 Our current studies on results of amplification 
hTERT gene, in comprising tumors samples with 
non-tumors is indication of early prognosis in 
primary breast cancer patients. While     
amplification of hTERT gene in breast cancer 
patients compared to the control group indicates that 
there is no statistical deference’s between them and it  
couldn’t be considered as prognosis factor for the 
primary breast cancer patients. 
 According to conducted research it could be 
suggested that the hTERT gene may be promoted 
through telomerase activity,  but increasing the copy 
number in various tumor cell line is not always 
dependent on telomerase activity  and it likely could 
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